Roche Holding AG RHHBY:OTCQX

RT Quote | Exchange | USD
Last | 05/14/21 EDT
42.13quote price arrow up+0.43 (+1.03%)
Volume
1,214,982
52 week range
39.72 - 47.15

...

Loading . . .
  • Open41.81
  • Day High42.22
  • Day Low41.81
  • Prev Close41.70
  • 52 Week High47.15
  • 52 Week High Date09/18/20
  • 52 Week Low39.72
  • 52 Week Low Date10/30/20

Key Stats

  • Market Cap290.718B
  • Shares Out6.901B
  • 10 Day Average Volume0.00M
  • Dividend1.22
  • Dividend Yield2.90%
  • Beta0.52
  • YTD % Change-3.9

KEY STATS

  • Open41.81
  • Day High42.22
  • Day Low41.81
  • Prev Close41.70
  • 52 Week High47.15
  • 52 Week High Date09/18/20
  • 52 Week Low39.72
  • 52 Week Low Date10/30/20
  • Market Cap290.718B
  • Shares Out6.901B
  • 10 Day Average Volume0.00M
  • Dividend1.22
  • Dividend Yield2.90%
  • Beta0.52
  • YTD % Change-3.9

RATIOS/PROFITABILITY

  • EPS (TTM)2.02
  • P/E (TTM)20.87
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)25.127B
  • ROE (MRQ)44.72%
  • Revenue (MRQ)62.913B
  • Gross Margin (MRQ)71.73%
  • Net Margin (MRQ)22.95%
  • Debt To Equity (MRQ)43.86%

EVENTS

  • Earnings Date-
  • Ex Div Date03/18/2021
  • Div Amount1.2205
  • Split Date-
  • Split Factor-

Latest On Roche Holding AG

Profile

MORE
Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including...
Christoph Franz Ph.D.
Non-Executive Chairman
Alan Hippe
Chief Financial Officer
Claudia Boeckstiegel
General Counsel
Address
Grenzacherstr. 124
Basel
4058
Switzerland

Top Peers

SYMBOLLASTCHG%CHG
PFE
Pfizer Inc
40.02-0.08-0.20%
ABBV
Abbvie Inc
116.43-0.17-0.15%
NVS
Novartis AG
88.96+0.56+0.63%
MRK
Merck & Co Inc
78.29-0.40-0.51%
BMY
Bristol-Myers Squibb Co
64.88-0.16-0.25%